PLA2G15 and lysosomal storage disease: Although the inhibition of both LPLA2 and lysosomal acid sphingomyelinase by drugs that cause phospholipidosis has been proposed to occur by inhibition of electrostatic interactions between the respective phospholipases and anionic lipids, this model would not explain the phospholipidosis observed by compounds that are not basic drugs.